Nestlé has initiated a recall of select batches of baby formula primarily in Europe over concerns of potential contamination with a toxin that can lead to symptoms such as nausea and vomiting. The company clarified that the recall does not impact any products in Canada.
The decision to recall certain products, including batches of SMA, BEBA, and NAN infant formulas, was taken as a precautionary measure due to the potential presence of a toxin known as cereulide in those specific batches. Cereulide is a toxin produced by a specific strain of bacteria that can cause food poisoning, resulting in severe vomiting and nausea lasting up to 24 hours, as highlighted by information from Ireland’s food inspection agency, which is among the affected countries.
In an effort to prioritize the safety and well-being of infants, Nestlé stated on its website that the voluntary recall aligns with their stringent product quality and safety standards. The company confirmed that no illnesses related to the recalled products have been reported.
Following the detection of a quality issue in an ingredient sourced from a supplier, Nestlé conducted testing on their products. Subsequently, the company has shifted to alternative suppliers to increase production and ensure continued availability of formula.
The recall affects several countries, including Turkey, Argentina, the U.K., Ireland, and various European nations. Nonetheless, Nestlé has assured that the recall does not extend to any products within Canada. Both Nestlé and the Canadian Food Inspection Agency (CFIA) have affirmed the absence of distribution of the affected formulas in Canada, with the CFIA pledging to notify the public promptly if any Canadian products are found to be impacted.
Consumers can find a list of affected batch numbers on Nestlé’s website, with batch codes located on the packaging of the formula. Nestlé advises consumers not to use the affected formulas and to contact the company for a refund if they have purchased any of the recalled products.
Austria’s health ministry reported that the recall affects over 800 products manufactured in more than 10 Nestlé factories, marking it as the largest recall in the company’s history. However, these figures have yet to be verified by Nestlé.
Nestlé, a Swiss multinational corporation, holds a significant market share in the global infant nutrition market. The company’s shares have experienced a decline of over three percent in recent trading sessions. Nestlé’s Nutrition and Health Science division, which includes infant formula, contributed to a substantial portion of the company’s total sales in 2024.
This recall, which commenced on a smaller scale in December, presents additional challenges for Philipp Navratil, Nestlé’s new chief executive, as he endeavors to drive growth through a comprehensive portfolio review following a period of organizational changes.
